| Description: |
AP - Pharmaceuticals maker Eli Lilly and Co. said Monday its first-quarter earnings slid 39 percent, hurt by charges related to restructuring and an acquisition. But the results exceeded Wall Street forecasts, and the company boosted its full-year financial targets. |